CN104524540A - Traditional Chinese medicine composition for treating gallbladder polyps - Google Patents
Traditional Chinese medicine composition for treating gallbladder polyps Download PDFInfo
- Publication number
- CN104524540A CN104524540A CN201510059361.8A CN201510059361A CN104524540A CN 104524540 A CN104524540 A CN 104524540A CN 201510059361 A CN201510059361 A CN 201510059361A CN 104524540 A CN104524540 A CN 104524540A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating gallbladder polyps. The traditional Chinese medicine composition contains the following substances in parts by weight: 10-20 parts of bupleurum root, 4-10 parts of scutellaria root, 10-20 parts of radix paeoniae alba, 3-9 parts of pinellia tuber, 5-15 parts of citrus aurantium, 10-20 parts of rhubarb root, 5-15 parts of rhizoma sparganii, 5-15 parts of zedoary, 5-15 parts of radix curcumae, 10-20 parts of codonopsis pilosula, 25-35 parts of lysimachia, 10-20 parts of parched hawthorn fruit, 10-20 parts of turtle shell, 25-35 parts of lonicera japonica, 5-15 parts of glycyrrhiza uralensis, 5-15 parts of Chuanxiong rhizome, 10-20 parts of spica prunellae, 15-22 parts of nutagrass flatsedge rhizome, 10-20 parts of amomum fruit, 10-20 parts of corydalis tuber, 5-15 parts of angelica sinensis, 10-20 parts of salvia miltiorrhiza, 5-15 parts of fried green tangerine peel, 10-20 parts of fried endothelium corneum gigeriae galli, 10-30 parts of zingiber officinale and 30-60 parts of Chinese date. The traditional Chinese medicine composition disclosed by the invention has a mutual effect and a synergistic effect and is remarkable in treatment effect, thereby being very worthy of vigorous popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of gallbladder polyp.
Background technology
Cystic polyp disease has relevant disease to discuss and treatment in motherland's Chinese medicine, such as: " rib pain ", " gallbladder-distention ", " painful abdominal mass " etc.Along with the development of science and technology, the guidance of modernization Medical Technology, the application of diagnostic instruments, gallbladder breath disease has had clear and definite Diagnosis and Treat, but Therapeutic Method is criterion of cure mainly with excision gallbladder, though good, but cause larger wound to patient's body because of operative treatment, spiritual torment and misery cannot be avoided.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of gallbladder polyp.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of gallbladder polyp, it comprises the material of following weight portion: Radix Bupleuri 10-20 part, Radix Scutellariae 4-10 part, Radix Paeoniae Alba 10-20 part, Rhizoma Pinelliae 3-9 part, Fructus Aurantii Immaturus 5-15 part, Radix Et Rhizoma Rhei 10-20 part, Rhizoma Sparganii 5-15 part, Rhizoma Curcumae 5-15 part, Radix Curcumae 5-15 part, Radix Codonopsis 10-20 part, Herba Lysimachiae 25-35 part, Fructus Crataegi (parched to brown) 10-20 part, Carapax Trionycis 10-20 part, Flos Lonicerae 25-35 part, Radix Glycyrrhizae 5-15 part, Rhizoma Chuanxiong 5-15 part, XIAKUQIU 10-20 part, Rhizoma Cyperi 15-22 part, Fructus Amomi 10-20 part, Rhizoma Corydalis 10-20 part, Radix Angelicae Sinensis 5-15 part, Radix Salviae Miltiorrhizae 10-20 part, parch skin 5-15 part, Endothelium Corneum Gigeriae Galli (parched) 10-20 part, Rhizoma Zingiberis Recens 10-30 part and Fructus Jujubae 30-60 part.
Preferably, the Chinese medicine composition of described treatment gallbladder polyp comprises the material of following weight portion: Radix Bupleuri 15 parts, Radix Scutellariae 5 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Pinelliae 5 parts, Fructus Aurantii Immaturus 10 parts, Radix Et Rhizoma Rhei 15 parts, Rhizoma Sparganii 10 parts, Rhizoma Curcumae 10 parts, Radix Curcumae 10 parts, Radix Codonopsis 15 parts, Herba Lysimachiae 30 parts, Fructus Crataegi (parched to brown) 15 parts, Carapax Trionycis 15 parts, Flos Lonicerae 30 parts, 10 parts, Radix Glycyrrhizae, Rhizoma Chuanxiong 10 parts, XIAKUQIU 15 parts, Rhizoma Cyperi 20 parts, Fructus Amomi 15, Rhizoma Corydalis 15 parts, Radix Angelicae Sinensis 10 parts, Radix Salviae Miltiorrhizae 15 parts, parch skin 10 parts, Endothelium Corneum Gigeriae Galli (parched) 15 parts, 20 parts, Rhizoma Zingiberis Recens and 50 parts, Fructus Jujubae.
Preferably, the Chinese medicine composition of described treatment gallbladder polyp also comprises the material of following weight portion: 15 parts, ten liang of leaves, Herba Zornia Diphyllae 8 parts, Radix Cacaliae Ainsliaeflorae 6 parts, Caulis Bauhihiae Championii 8 parts, triangle steep 5 parts, Herba Schizonepetae 8 parts, Caulis et Folium Pavettae Hongkongensis 7 parts, Galeola faberi 5 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Ligustri Lucidi 12 parts, Herba Melandrii Aprici 10 parts, Semen Oroxyli 5 parts and ipomoea cairica 7 parts.
Preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, decoction or ointment.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment gallbladder polyp, described compositions comprises the material of following weight portion: Radix Bupleuri 10-20 part, Radix Scutellariae 4-10 part, Radix Paeoniae Alba 10-20 part, Rhizoma Pinelliae 3-9 part, Fructus Aurantii Immaturus 5-15 part, Radix Et Rhizoma Rhei 10-20 part, Rhizoma Sparganii 5-15 part, Rhizoma Curcumae 5-15 part, Radix Curcumae 5-15 part, Radix Codonopsis 10-20 part, Herba Lysimachiae 25-35 part, Fructus Crataegi (parched to brown) 10-20 part, Carapax Trionycis 10-20 part, Flos Lonicerae 25-35 part, Radix Glycyrrhizae 5-15 part, Rhizoma Chuanxiong 5-15 part, XIAKUQIU 10-20 part, Rhizoma Cyperi 15-22 part, Fructus Amomi 10-20 part, Rhizoma Corydalis 10-20 part, Radix Angelicae Sinensis 5-15 part, Radix Salviae Miltiorrhizae 10-20 part, parch skin 5-15 part, Endothelium Corneum Gigeriae Galli (parched) 10-20 part, Rhizoma Zingiberis Recens 10-30 part and Fructus Jujubae 30-60 part.
Preferably, described compositions comprises the material of following weight portion: Radix Bupleuri 15 parts, Radix Scutellariae 5 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Pinelliae 5 parts, Fructus Aurantii Immaturus 10 parts, Radix Et Rhizoma Rhei 15 parts, Rhizoma Sparganii 10 parts, Rhizoma Curcumae 10 parts, Radix Curcumae 10 parts, Radix Codonopsis 15 parts, Herba Lysimachiae 30 parts, Fructus Crataegi (parched to brown) 15 parts, Carapax Trionycis 15 parts, Flos Lonicerae 30 parts, 10 parts, Radix Glycyrrhizae, Rhizoma Chuanxiong 10 parts, XIAKUQIU 15 parts, Rhizoma Cyperi 20 parts, Fructus Amomi 15, Rhizoma Corydalis 15 parts, Radix Angelicae Sinensis 10 parts, Radix Salviae Miltiorrhizae 15 parts, parch skin 10 parts, Endothelium Corneum Gigeriae Galli (parched) 15 parts, 20 parts, Rhizoma Zingiberis Recens and 50 parts, Fructus Jujubae.
Preferably, described compositions also comprises the material of following weight portion: 15 parts, ten liang of leaves, Herba Zornia Diphyllae 8 parts, Radix Cacaliae Ainsliaeflorae 6 parts, Caulis Bauhihiae Championii 8 parts, triangle steep 5 parts, Herba Schizonepetae 8 parts, Caulis et Folium Pavettae Hongkongensis 7 parts, Galeola faberi 5 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Ligustri Lucidi 12 parts, Herba Melandrii Aprici 10 parts, Semen Oroxyli 5 parts and ipomoea cairica 7 parts.
Preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, decoction or ointment.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 decoction of the present invention
Take Radix Bupleuri 15 grams, Radix Scutellariae 5 grams, the Radix Paeoniae Alba 15 grams, the Rhizoma Pinelliae 5 grams, Fructus Aurantii Immaturus 10 grams, Radix Et Rhizoma Rhei 15 grams, Rhizoma Sparganii 10 grams, Rhizoma Curcumae 10 grams, Radix Curcumae 10 grams, Radix Codonopsis 15 grams, Herba Lysimachiae 30 grams, Fructus Crataegi (parched to brown) 15 grams, Carapax Trionycis 15 grams, Flos Lonicerae 30 grams, 10 grams, Radix Glycyrrhizae, Rhizoma Chuanxiong 10 grams, XIAKUQIU 15 grams, Rhizoma Cyperi 20 grams, Fructus Amomi 15, Rhizoma Corydalis 15 grams, Radix Angelicae Sinensis 10 grams, Radix Salviae Miltiorrhizae 15 grams, parch skin 10 grams, Endothelium Corneum Gigeriae Galli (parched) 15 grams, 20 grams, Rhizoma Zingiberis Recens and 50 grams, Fructus Jujubae, pulverize, cross 30 mesh sieves, add 8000 ml waters, heating 5 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature, obtain.
Embodiment 2 decoction of the present invention
Take Radix Bupleuri 15 grams, Radix Scutellariae 5 grams, the Radix Paeoniae Alba 15 grams, the Rhizoma Pinelliae 5 grams, Fructus Aurantii Immaturus 10 grams, Radix Et Rhizoma Rhei 15 grams, Rhizoma Sparganii 10 grams, Rhizoma Curcumae 10 grams, Radix Curcumae 10 grams, Radix Codonopsis 15 grams, Herba Lysimachiae 30 grams, Fructus Crataegi (parched to brown) 15 grams, Carapax Trionycis 15 grams, Flos Lonicerae 30 grams, 10 grams, Radix Glycyrrhizae, Rhizoma Chuanxiong 10 grams, XIAKUQIU 15 grams, Rhizoma Cyperi 20 grams, Fructus Amomi 15, Rhizoma Corydalis 15 grams, Radix Angelicae Sinensis 10 grams, Radix Salviae Miltiorrhizae 15 grams, parch skin 10 grams, Endothelium Corneum Gigeriae Galli (parched) 15 grams, 20 grams, Rhizoma Zingiberis Recens, 50 grams, Fructus Jujubae, 15 grams, ten liang of leaves, Herba Zornia Diphyllae 8 grams, Radix Cacaliae Ainsliaeflorae 6 grams, Caulis Bauhihiae Championii 8 grams, triangle steeps 5 grams, Herba Schizonepetae 8 grams, Caulis et Folium Pavettae Hongkongensis 7 grams, Galeola faberi 5 grams, Fructus Schisandrae Chinensis 15 grams, Fructus Ligustri Lucidi 12 grams, Herba Melandrii Aprici 10 grams, Semen Oroxyli 5 grams and ipomoea cairica 7 grams, pulverize, cross 30 mesh sieves, add 8000 ml waters, heating 5 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature, obtain.
Experimental example
Meet following standard and can include investigation case in: 1. confirm Gallbladder polypoid disease person with color ultrasound examination; 3mm < polyp size < 8mm; The polyp band base of a fruit or narrow base; 2. 18 years old < age < 55 years old; 3. asymptomatic, or only have some non-specific symptoms: as upper right abdomen dull pain, right shoulder radiating pain, can accompany and see (or do not accompany see) to feel sick, anorexia, abdominal distention is uncomfortable; 4. be reluctant that row cholecystectomy or polyp extract patient.
Exclusion standard
Have any one person following then this patient can not be included into: 1. have systemic disease or the psychotic such as severe cardiac, lung, liver, kidney; 2. woman gestationperiod and age of sucking patient; 3. increase tendency is obvious in a short time for polyp; 4. cholelithiasis is merged; 5. gallbladder contraction function difference person.
Selector close state patient 46 example, wherein man 24 example, female 22 example, age 21-53 year, 41.5 years old mean age; Companion's cholecystitis 12 example, cholelithiasis 8 example.Be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 23 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the decoction of preparation in embodiment 1 to treat, every day twice, oral 100 milliliters at every turn, continuously treatment 5 weeks.
Treatment group 2 uses the decoction of preparation in embodiment 2 to treat, every day twice, oral 100 milliliters at every turn, continuously treatment 5 weeks.
Criterion of therapeutical effect
Clinical symptom disappearance, ultrasound diagnosis shows that cystic polyp disappears for curing.Take a turn for the better: clinical symptom disappearance, B ultrasonic check cystic polyp many pieces reduces and single piece of polyp reduces.Invalid: clinical symptom relief, but cystic polyp is unchanged.
Statistical method
Utilize SPSS 13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts x
2inspection, P < 0.05 represents that difference has statistical significance.
Result
Through treatment, for treatment group 1, cure 11 examples, take a turn for the better 7 examples, invalid 5 examples, and total effective rate is 78.3%, for treatment group 2, cures 13 examples, and take a turn for the better 8 examples, and invalid 2 examples, total effective rate is 91.3%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).
Untoward reaction and toxic and side effects supervision
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Find that the systolic pressure of all patients is between 90-140mmHg, diastolic pressure is between 60-90mmHg, and pulse is 60-100 beat/min, and blood pressure and pulse all within normal range, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that medicine does not have obvious toxic and side effects for human body.
Model case
Hu, male, 33 years old, because dull pain discomfort in right flank portion is medical, haves a medical check-up: light red tongue, white and thin fur, stringy and thready pulse; Abdomen is put down soft, the light tenderness of upper right abdomen, without rebound tenderness, and murphy sign (±).Color ultrasound is shown: gallbladder wall is crude, Gallbladder polypoid change (size is about 3mm × 4mm).Patient is reluctant operation to use the decoction of preparation in embodiment 1 to treat, every day twice, oral 100 milliliters at every turn, treatment 5 weeks continuously.Clinical symptom disappearance, ultrasound diagnosis shows that cystic polyp disappears.And patient does not find obvious untoward reaction.
Claims (8)
1. treat the Chinese medicine composition of gallbladder polyp for one kind, it is characterized in that, it comprises the material of following weight portion: Radix Bupleuri 10-20 part, Radix Scutellariae 4-10 part, Radix Paeoniae Alba 10-20 part, Rhizoma Pinelliae 3-9 part, Fructus Aurantii Immaturus 5-15 part, Radix Et Rhizoma Rhei 10-20 part, Rhizoma Sparganii 5-15 part, Rhizoma Curcumae 5-15 part, Radix Curcumae 5-15 part, Radix Codonopsis 10-20 part, Herba Lysimachiae 25-35 part, Fructus Crataegi (parched to brown) 10-20 part, Carapax Trionycis 10-20 part, Flos Lonicerae 25-35 part, Radix Glycyrrhizae 5-15 part, Rhizoma Chuanxiong 5-15 part, XIAKUQIU 10-20 part, Rhizoma Cyperi 15-22 part, Fructus Amomi 10-20 part, Rhizoma Corydalis 10-20 part, Radix Angelicae Sinensis 5-15 part, Radix Salviae Miltiorrhizae 10-20 part, parch skin 5-15 part, Endothelium Corneum Gigeriae Galli (parched) 10-20 part, Rhizoma Zingiberis Recens 10-30 part and Fructus Jujubae 30-60 part.
2. the Chinese medicine composition for the treatment of gallbladder polyp according to claim 1, it is characterized in that, it comprises the material of following weight portion: Radix Bupleuri 15 parts, Radix Scutellariae 5 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Pinelliae 5 parts, Fructus Aurantii Immaturus 10 parts, Radix Et Rhizoma Rhei 15 parts, Rhizoma Sparganii 10 parts, Rhizoma Curcumae 10 parts, Radix Curcumae 10 parts, Radix Codonopsis 15 parts, Herba Lysimachiae 30 parts, Fructus Crataegi (parched to brown) 15 parts, Carapax Trionycis 15 parts, Flos Lonicerae 30 parts, 10 parts, Radix Glycyrrhizae, Rhizoma Chuanxiong 10 parts, XIAKUQIU 15 parts, Rhizoma Cyperi 20 parts, Fructus Amomi 15, Rhizoma Corydalis 15 parts, Radix Angelicae Sinensis 10 parts, Radix Salviae Miltiorrhizae 15 parts, parch skin 10 parts, Endothelium Corneum Gigeriae Galli (parched) 15 parts, 20 parts, Rhizoma Zingiberis Recens and 50 parts, Fructus Jujubae.
3. the Chinese medicine composition for the treatment of gallbladder polyp according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: 15 parts, ten liang of leaves, Herba Zornia Diphyllae 8 parts, Radix Cacaliae Ainsliaeflorae 6 parts, Caulis Bauhihiae Championii 8 parts, triangle steep 5 parts, Herba Schizonepetae 8 parts, Caulis et Folium Pavettae Hongkongensis 7 parts, Galeola faberi 5 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Ligustri Lucidi 12 parts, Herba Melandrii Aprici 10 parts, Semen Oroxyli 5 parts and ipomoea cairica 7 parts.
4. the Chinese medicine composition for the treatment of gallbladder polyp according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, decoction or ointment.
5. the purposes of compositions in the Chinese medicine of preparation treatment gallbladder polyp, it is characterized in that, described compositions comprises the material of following weight portion: Radix Bupleuri 10-20 part, Radix Scutellariae 4-10 part, Radix Paeoniae Alba 10-20 part, Rhizoma Pinelliae 3-9 part, Fructus Aurantii Immaturus 5-15 part, Radix Et Rhizoma Rhei 10-20 part, Rhizoma Sparganii 5-15 part, Rhizoma Curcumae 5-15 part, Radix Curcumae 5-15 part, Radix Codonopsis 10-20 part, Herba Lysimachiae 25-35 part, Fructus Crataegi (parched to brown) 10-20 part, Carapax Trionycis 10-20 part, Flos Lonicerae 25-35 part, Radix Glycyrrhizae 5-15 part, Rhizoma Chuanxiong 5-15 part, XIAKUQIU 10-20 part, Rhizoma Cyperi 15-22 part, Fructus Amomi 10-20 part, Rhizoma Corydalis 10-20 part, Radix Angelicae Sinensis 5-15 part, Radix Salviae Miltiorrhizae 10-20 part, parch skin 5-15 part, Endothelium Corneum Gigeriae Galli (parched) 10-20 part, Rhizoma Zingiberis Recens 10-30 part and Fructus Jujubae 30-60 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Radix Bupleuri 15 parts, Radix Scutellariae 5 parts, the Radix Paeoniae Alba 15 parts, the Rhizoma Pinelliae 5 parts, Fructus Aurantii Immaturus 10 parts, Radix Et Rhizoma Rhei 15 parts, Rhizoma Sparganii 10 parts, Rhizoma Curcumae 10 parts, Radix Curcumae 10 parts, Radix Codonopsis 15 parts, Herba Lysimachiae 30 parts, Fructus Crataegi (parched to brown) 15 parts, Carapax Trionycis 15 parts, Flos Lonicerae 30 parts, 10 parts, Radix Glycyrrhizae, Rhizoma Chuanxiong 10 parts, XIAKUQIU 15 parts, Rhizoma Cyperi 20 parts, Fructus Amomi 15, Rhizoma Corydalis 15 parts, Radix Angelicae Sinensis 10 parts, Radix Salviae Miltiorrhizae 15 parts, parch skin 10 parts, Endothelium Corneum Gigeriae Galli (parched) 15 parts, 20 parts, Rhizoma Zingiberis Recens and 50 parts, Fructus Jujubae.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: 15 parts, ten liang of leaves, Herba Zornia Diphyllae 8 parts, Radix Cacaliae Ainsliaeflorae 6 parts, Caulis Bauhihiae Championii 8 parts, triangle steep 5 parts, Herba Schizonepetae 8 parts, Caulis et Folium Pavettae Hongkongensis 7 parts, Galeola faberi 5 parts, Fructus Schisandrae Chinensis 15 parts, Fructus Ligustri Lucidi 12 parts, Herba Melandrii Aprici 10 parts, Semen Oroxyli 5 parts and ipomoea cairica 7 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, decoction or ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510059361.8A CN104524540A (en) | 2015-02-04 | 2015-02-04 | Traditional Chinese medicine composition for treating gallbladder polyps |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510059361.8A CN104524540A (en) | 2015-02-04 | 2015-02-04 | Traditional Chinese medicine composition for treating gallbladder polyps |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104524540A true CN104524540A (en) | 2015-04-22 |
Family
ID=52840296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510059361.8A Pending CN104524540A (en) | 2015-02-04 | 2015-02-04 | Traditional Chinese medicine composition for treating gallbladder polyps |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104524540A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107137663A (en) * | 2017-05-18 | 2017-09-08 | 张新雨 | One kind treats carcinoid Chinese medicinal formulae in gall-bladder |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1132643A (en) * | 1995-12-01 | 1996-10-09 | 冯学祯 | Medicine for diseases of liver and gall |
-
2015
- 2015-02-04 CN CN201510059361.8A patent/CN104524540A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1132643A (en) * | 1995-12-01 | 1996-10-09 | 冯学祯 | Medicine for diseases of liver and gall |
Non-Patent Citations (4)
| Title |
|---|
| 侯智亮等: "清胆汤治疗慢性胆囊炎174例", 《中国中西医结合外科杂志》 * |
| 马建伟等: "《中医防治消化及呼吸系统肿瘤》", 31 January 2005, 贵州科技出版社 * |
| 黄兆鋆: "胆病验案三则", 《上海中医药杂志》 * |
| 黄秀玲等: "疏肝理气活血化瘀法治疗胆心综合征", 《吉林中医药》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107137663A (en) * | 2017-05-18 | 2017-09-08 | 张新雨 | One kind treats carcinoid Chinese medicinal formulae in gall-bladder |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463568B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN105902906A (en) | Traditional Chinese medicine composition for treating wind-cold-type cold and cough and preparation method thereof | |
| CN1150928C (en) | Medicine for curing cancers and its preparation method | |
| CN102727779B (en) | Pharmaceutical composition for treating ovarian cysts and preparation method thereof | |
| CN102600426B (en) | Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN102688445B (en) | Traditional Chinese medicine for treating diabetes and preparation method thereof | |
| CN103356932B (en) | A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia | |
| CN104587267A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN104524540A (en) | Traditional Chinese medicine composition for treating gallbladder polyps | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN101502583A (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN102895580B (en) | Pulse invigorating and kidney tonifying medicament | |
| CN102988890A (en) | Pure Chinese medicine preparation for treating chloasma | |
| CN107213219A (en) | Treat the Chinese medicine preparation of cardiovascular and cerebrovascular disease | |
| CN102166303B (en) | Chinese medicinal composition for treating chronic atrophic gastritis | |
| CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
| CN100411670C (en) | Medicine for treating tumor in upper digestive tract and its preparing method | |
| CN105749243A (en) | Traditional Chinese medicine for treating coolness diseases | |
| CN105168774A (en) | Traditional Chinese medicine preparation for treating scapulohumeral periarthritis and preparation method thereof | |
| CN104815199A (en) | Traditional Chinese medicinal composition for treating ascites due to cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150422 |
|
| RJ01 | Rejection of invention patent application after publication |